Reid Waldman
Vermogen: 29 M $ op 30-06-2026
Vermogen: 29 M $ op 30-06-2026
Reid Waldman is the founder of Veradermics, Inc., founded in 2019, holding the title of Chief Executive Officer & Director since 2022.
Dr. Waldman currently holds the position of Director at Achieve Life Sciences, Inc., starting in 2026.
Dr. Waldman completed undergraduate and doctorate degrees at the University of Missouri-Kansas City.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-02-2026 | 234.872 ( 0,56% ) | 29 M $ | 30-06-2026 | |
| 29-05-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| VERADERMICS, INCORPORATED | Oprichter | 01-01-2019 |
| ACHIEVE LIFE SCIENCES, INC. | Directeur/Bestuurslid | 29-05-2026 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
University of Missouri-Kansas City
University of Missouri-Kansas City Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Veradermics, Inc.
Veradermics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company for treatment of dermatology and aesthetics problems | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau